Last updated: 2026-09-30 21:13:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Guardant Health, Inc. (GH) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $178.59, with a market capitalization of $23.80B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $60.45 to $183.51. This page covers its latest market performance, valuation, price trends and company information.
$23.80B | |
$177.75 | |
$183.51 | |
$15.81 | |
$177.73 | |
1.25M | |
2.14M | |
-- | |
$183.51 | |
$60.45 | |
-- | |
-- |
Guardant Health, Inc. (GH) is trading at $178.50 in after-hours trading as of 2026-09-30 21:06:00, up 0.43% ($0.77) from the regular-session close of $177.73.
After-hours trading shows how investors are pricing GH after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Guardant Health, Inc. (GH) moved from $173.87 to $178.59, representing a gain of 2.72% ($4.72).
The stock traded between $170.50 and $181.79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.92 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 96.0%
GH is currently trading at $178.59, placing it 96.0% of the way from its 52-week low of $60.45 to its 52-week high of $183.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 2506 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Guardant Health, Inc. (GH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.